Literature DB >> 21872762

Cell-based therapies for equine joint disease.

David D Frisbie1, Matthew C Stewart.   

Abstract

Joint disease is a major cause of wastage in performance horses. Arthritis can be challenging to treat because articular cartilage has little or no capacity for repair, therapeutic options are limited and are largely targeted at ameliorating clinical signs of joint disease. Cell-based therapies have potential to overcome the intrinsic constraints to articular cartilage repair. This article focuses on cell-based therapies for treatment of equine joint disease. Results from experimental model and human clinical studies are presented along with available data from equine studies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21872762     DOI: 10.1016/j.cveq.2011.06.005

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  4 in total

1.  Platelet-Rich Gel Supernatants Stimulate the Release of Anti-Inflammatory Proteins on Culture Media of Normal Equine Synovial Membrane Explants.

Authors:  Diana L Ríos; Catalina López; Jorge U Carmona
Journal:  Vet Med Int       Date:  2015-05-18

2.  Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.

Authors:  Lynn M Pezzanite; Lisa A Fortier; Douglas F Antczak; Jennifer M Cassano; Margaret M Brosnahan; Donald Miller; Lauren V Schnabel
Journal:  Stem Cell Res Ther       Date:  2015-04-12       Impact factor: 6.832

3.  Synovium extra cellular matrices seeded with transduced mesenchymal stem cells stimulate chondrocyte maturation in vitro and cartilage healing in clinically-induced rat-knee lesions in vivo.

Authors:  Nathalie A Reisbig; Erin Pinnell; Logan Scheuerman; Hayam Hussein; Alicia L Bertone
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

4.  Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro.

Authors:  Lauren V Schnabel; Lynn M Pezzanite; Douglas F Antczak; M Julia Bevilaqua Felippe; Lisa A Fortier
Journal:  Stem Cell Res Ther       Date:  2014-01-24       Impact factor: 6.832

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.